The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will gather information on the effectiveness and safety of a treatment program for
small cell lung cancer (SCLC) that uses an FDA approved chemotherapy combination, radiation
therapy, and an oral investigational drug that may enhance the effects of radiation therapy.
Study patients will receive two additional courses of the standard chemotherapy combination
after completing radiation therapy.